Stock

CNS Pharmaceuticals, Inc. CNSP

$5.80+13.50%

All stocks Create account to unlock

Overview

CNSP market data

Price History

CNSP price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for CNSP. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

3 captured

8-K filing — CNS Pharmaceuticals, Inc. (CNSP) · Jul 2, 2026, 11:30 AM

Glioblastoma Multiforme Market Poised for Significant Growth at a CAGR of 13.2% During the Forecast Period (2026–2036), as Next-Generation Therapies Enter Late-Stage Development | DelveInsight · May 27, 2026, 5:15 PM

CNS Pharmaceuticals Q1 EPS $(7.30) Misses $(5.37) Estimate · May 14, 2026, 12:28 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock